Diversity and Inclusion in Clinical Trials: Concrete Strategies for Enhancing Health Equity

1:45 PM - 2:45 PM (PDT), Tuesday, June 14, 2022

Enhancing diversity and inclusion in clinical studies is critical to closing the health equity gap. Clinical researchers should ensure clinical trials reflect the intended treatment population.
This forum will explore emerging principles and concrete strategies for addressing demographic disparities and achieving representativeness in clinical trials. The moderator will focus on initiatives to enhance diversity and inclusion in clinical trials. We will present emerging principles regarding what constitutes acceptable diversity in clinical studies and share insights into how engaging with clinicians and patients in underrepresented communities can help to achieve diversity and inclusion in the study of medical products to prevent and to treat disease.


 


 

Moderator
photo
US Policy & Strategy Head
BeiGene, Ltd.
Speakers
photo
Chief Corporate Affairs Officer
Ovid Therapeutics Inc.
photo
Principal Deputy Center Director
FDA
photo
Senior Vice President, Global Clinical Operations
BeiGene, USA, Inc.
photo
Program Manager
MRCT Center of Harvard and BWH
photo
Deputy Director and Chief Operating Officer, YCCI; Director of Clinical Research, YSM
YALE UNIVERSITY